Ocriplasmin - variable efficacy?

Graefes Arch Clin Exp Ophthalmol. 2016 Jul;254(7):1245-6. doi: 10.1007/s00417-016-3404-0. Epub 2016 Jun 4.

Authors

David H W Steel^{1

2}, David Wong³

Affiliations

¹ Sunderland Eye Infirmary, Queen Alexandra Road, Sunderland, UK. David.steel@ncl.ac.uk.
² Institute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, UK. David.steel@ncl.ac.uk.
³ St. Paul's Eye Unit, Royal Liverpool University Hospital Trust, Liverpool, UK.

PMID: 27262728
DOI: 10.1007/s00417-016-3404-0

No abstract available

Publication types

Editorial

MeSH terms

Fibrinolysin / administration & dosage*
Humans
Intravitreal Injections
Peptide Fragments / administration & dosage*
Retinal Diseases / drug therapy
Treatment Outcome

Substances

Peptide Fragments
microplasmin
Fibrinolysin